Prognostic and predictive factors in breast cancer
- 1 June 2001
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 27 (3) , 137-142
- https://doi.org/10.1053/ctrv.2000.0207
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Standards for diagnosis and management of invasive breast carcinoma. American College of Radiology. American College of Surgeons. College of American Pathologists. Society of Surgical Oncology.CA: A Cancer Journal for Clinicians, 1998
- Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients.Journal of Clinical Oncology, 1997
- Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.Journal of Clinical Oncology, 1996
- ABC of breast diseases: Role of Systemic Treatment for Primary Operable Breast CancerBMJ, 1994
- The Nottingham prognostic index in primary breast cancerBreast Cancer Research and Treatment, 1992
- Axillary dissection of level I and II lymph nodes is important in breast cancer classificationEuropean Journal Of Cancer, 1992
- Breast Cancer Prognostic Factors: Evaluation GuidelinesJNCI Journal of the National Cancer Institute, 1991
- Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP updateCancer, 1983